The Scientific Research Team at Celcuity conducts advanced research to develop and validate companion diagnostics (CDx) using the CELsignia platform. They focus on identifying biomarkers and therapeutic targets to optimize cancer treatment strategies, working collaboratively to support the clinical development and regulatory approval of new diagnostic and therapeutic products.
View all